Susha Cheriyedath is a Feature Writer at Azom.com Limited. With a Master's degree in Biochemistry and nearly two decades of experience in medical communication, she specializes in medicine and healthcare, alternative medicine, and wellness, with a keen focus on diet and nutrition, including veganism. Susha's work has been featured in prominent platforms such as AZoOptics, AZoQuantum, and News Medical.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Susha's coverage heavily relies on citing data, indicating a strong preference for evidence-based information. She predominantly covers scientific and healthcare topics, with a focus on health and medicine, genetics, diseases, vaccines, and COVID-19.
For pitching to Susha Cheriyedath:
1. Provide well-researched data-driven insights or studies related to the latest developments in healthcare and medicine.
2. Consider offering interviews with experts who have conducted significant research in the areas of Alzheimer's disease subtypes, long-term effects of COVID-19 on brain function and structure as well as T-cell immunity against SARS-CoV-2 variants.
3. Highlight groundbreaking genetic studies related to insulin resistance and BMI differences across socio-economic groups.
4. Propose information regarding the effectiveness of bivalent COVID-19 vaccines against thromboembolic events or the impact of plant-based diets in reducing COVID risk.
Given her heavy reliance on cited data sources for articles covering scientific and healthcare topics such as new findings about diseases or treatments like Paxlovid for COVID-19 patients—pitching scientifically-backed stories or expert commentary rooted in robust research would likely appeal most to her editorial interests.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Hugo Francisco, Susha Cheriyedath
A three-day psilocybin regimen after repeated head impacts gave researchers a rare look at how the psychedelic may influence brain swelling, vascular function, neural networks, tau, and molecular pathways involved in recovery.
By: Susha Cheriyedath, Vijay Kumar Malesu
Six different protein-based aging clocks tracked how an experimental IPF drug reshaped biological age signals, revealing a striking disconnect between lung function improvement and broader proteomic responses.
By: Tarun Sai Lomte, Susha Cheriyedath
Could a lower, better-tolerated dose of an established muscle relaxant help prevent episodic migraine?
By: Susha Cheriyedath, Akshatha Chandrashekar
By building microscopic copper coils vertically above chip contact pads, researchers tested whether RF inductors can escape the planar space constraints that have long complicated circuit miniaturization.
By: Susha Cheriyedath, Pooja Toshniwal Paharia
A controlled feeding trial reveals striking differences in how refined starch and added sugar affect immune cells after substantial weight loss on a very-low-carbohydrate diet.
By: Susha Cheriyedath, Hugo Francisco
A head-to-head comparison of five leading LLMs tested what happens when breast cancer questions move from textbook knowledge to clinical cases and the everyday concerns patients bring to their care teams.
By: Tarun Sai Lomte, Susha Cheriyedath
A multiethnic cohort study separated total, caffeinated, and decaffeinated coffee intake and tracked long-term survival after colorectal cancer diagnosis, revealing a more complex picture than coffee alone.
By: Susha Cheriyedath, Vijay Kumar Malesu
From altered brain energy metabolism to inflammation and neurotransmitter signaling, researchers examine why raising ketone levels has drawn interest as a potential metabolic approach to PTSD.
By: Susha Cheriyedath, Akshatha Chandrashekar
From ceria water-splitting cycles to rare-earth-doped electrodes and photocatalysts, researchers are examining which material properties matter most for cleaner hydrogen production.
By: Susha Cheriyedath, Ankit Singh
Every event in spacetime carries a cone attached to it. That cone represents the possible paths light can travel to and from that event.
